Innovative Medicine
-
INCIVO® (telaprevir) Demonstrates Efficacy and Increased Cure Rates among Cirrhotic Patients with Genotype-1 Chronic HCV Compared to Standard of Care
Data presented at AASLD 2011 highlights efficacy in typically hard to treat patients -
Tibotec To Present Final Safety And Efficacy Results From Phase 2b PILLAR Study Of Once-Daily TMC435 In Late-Breaker At AASLD
Data Show High Rates Of Virologic Response And Shortened Treatment Duration; Safety And Tolerability Comparable To Placebo -
FDA Approves XARELTO® (Rivaroxaban) To Reduce The Risk Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation
XARELTO® Combines Proven Effectiveness And Demonstrated Safety Profile With Convenient, Once-Daily Dosing -
-
-
-
-
Casey Abrams Announces Finalists in National Inflammatory Bowel Disease Awareness Campaign and Calls on America to Vote
After opening up about his own battle with Ulcerative Colitis, season 10 American Idol contestant Casey Abrams pledges to shave his signature beard if 1,500 people join the cause at IBDIcons.com -